Pharmaceutical Serialization Further Expands Laminate Specification
Pharmaceutical brands increasingly specify multi-layer barrier laminates previously limited to simple food sachet lines, applying it across an expanding list of serialized blister formats as regulatory expansion increasingly makes documented barrier certification a measurable production-capacity consideration rather than a manageable compliance detail. This shift is creating substantial new demand beyond the category's traditional food base, giving barrier-capable converters a genuine growth avenue tied to pharmaceutical expansion rather than pure food volume growth. Converters with established pharmaceutical brand relationships are capturing disproportionate share of this expanding demand across newly converted accounts worldwide.
Market Impact: Sustains 26% of food laminate volume








